These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33776946)

  • 1. Editorial: The Role of Ceramides in Diabetes and Cardiovascular Disease.
    Summers SA
    Front Endocrinol (Lausanne); 2021; 12():667885. PubMed ID: 33776946
    [No Abstract]   [Full Text] [Related]  

  • 2. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.
    Park TS; Goldberg IJ
    Heart Fail Clin; 2012 Oct; 8(4):633-41. PubMed ID: 22999245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart in diabetes: a microvascular disease.
    Laakso M
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S145-9. PubMed ID: 21525446
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
    Ussher JR
    Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iatrogenic hypoglycemia and cardiovascular risk in type 2 diabetes].
    Consoli A; Di Fulvio P
    G Ital Cardiol (Rome); 2012 Dec; 13(12):787-92. PubMed ID: 23196681
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.
    Field BC; Gordillo R; Scherer PE
    Front Endocrinol (Lausanne); 2020; 11():569250. PubMed ID: 33133017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.
    Kok BP; Brindley DN
    Heart Fail Clin; 2012 Oct; 8(4):643-61. PubMed ID: 22999246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered mitochondrial metabolism in the insulin-resistant heart.
    Makrecka-Kuka M; Liepinsh E; Murray AJ; Lemieux H; Dambrova M; Tepp K; Puurand M; Käämbre T; Han WH; de Goede P; O'Brien KA; Turan B; Tuncay E; Olgar Y; Rolo AP; Palmeira CM; Boardman NT; Wüst RCI; Larsen TS
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13430. PubMed ID: 31840389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New drugs for type 2 diabetes: expanding cardiovascular protection beyond type 2 diabetes?].
    Mannucci E
    G Ital Cardiol (Rome); 2012 Dec; 13(12 Suppl 1):3S. PubMed ID: 23258122
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinase-SUMO networks in diabetes-mediated cardiovascular disease.
    Chang E; Abe JI
    Metabolism; 2016 May; 65(5):623-633. PubMed ID: 27085771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of Cardiovascular Disease in Diabetes.
    Haas AV; McDonnell ME
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):51-63. PubMed ID: 29407056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes cardiovascular complications.
    Emanueli C
    Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):105-6. PubMed ID: 22663760
    [No Abstract]   [Full Text] [Related]  

  • 14. Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.
    Bayeva M; Sawicki KT; Ardehali H
    J Am Heart Assoc; 2013 Nov; 2(6):e000433. PubMed ID: 24275630
    [No Abstract]   [Full Text] [Related]  

  • 15. High fat diet induced diabetic cardiomyopathy.
    Dirkx E; Schwenk RW; Glatz JF; Luiken JJ; van Eys GJ
    Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):219-25. PubMed ID: 21571515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling.
    Smani T; Gallardo-Castillo I; Ávila-Médina J; Jimenez-Navarro MF; Ordoñez A; Hmadcha A
    Curr Med Chem; 2019; 26(22):4166-4177. PubMed ID: 28545369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
    Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ceramides in the pathogenesis of diabetes mellitus and its complications.
    Mandal N; Grambergs R; Mondal K; Basu SK; Tahia F; Dagogo-Jack S
    J Diabetes Complications; 2021 Feb; 35(2):107734. PubMed ID: 33268241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.
    Forte M; Palmerio S; Bianchi F; Volpe M; Rubattu S
    J Mol Med (Berl); 2019 May; 97(5):579-591. PubMed ID: 30863992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes.
    Packer M
    Diabetes Obes Metab; 2019 Aug; 21(8):1765-1768. PubMed ID: 31144444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.